Novel tumor-targeted liposomes comprised of an MDM2 antagonist plus proteasome inhibitor display anti-tumor activity in a xenograft model of bortezomib-resistant Waldenstrom macroglobulinemia (Q96587712)
Jump to navigation
Jump to search
scientific article published on 19 June 2020
Language | Label | Description | Also known as |
---|---|---|---|
English | Novel tumor-targeted liposomes comprised of an MDM2 antagonist plus proteasome inhibitor display anti-tumor activity in a xenograft model of bortezomib-resistant Waldenstrom macroglobulinemia |
scientific article published on 19 June 2020 |
Statements
Novel tumor-targeted liposomes comprised of an MDM2 antagonist plus proteasome inhibitor display anti-tumor activity in a xenograft model of bortezomib-resistant Waldenstrom macroglobulinemia (English)
Debabrata Mukhopadhyay
Aneel Paulus
Sharoon Akhtar
Alak Manna
Harikrishna Reddy Rachamalla
RajKumar Banerjee